Brazilian Tuberculosis Research Network to Evaluate PharmaJet(R) Needle-free Tropis(R) ID Injection Device as Delivery System for Tuberculin Skin Test

PharmaJet's Needle-free intradermal (ID) injection device ("Tropis(R) ID") will be evaluated as delivery system for the tuberculin skin test (TST) in a clinical study conducted by REDE-TB. -- The ...
Business Wire

WHO Launching Polio Eradication Campaign in Pakistan Using PharmaJet Precision Delivery System

5 million Needle-free PharmaJet Tropis ® ID syringes are being provided for polio immunization campaigns. Published results show that the Tropis System is a preferred and effective solution to help ...
Morningstar

PharmaJet’s Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...
Morningstar

PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference

PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference PharmaJet will deliver two presentations on ...
Business Insider

PharmaJet's Revolutionary Needle-free Drug Delivery Technology Earns Applause from Frost & Sullivan

Proprietary technology positioned to become the new standard of care in global drug delivery SANTA CLARA, Calif., Oct. 2, 2018 /PRNewswire/ -- Based on its recent analysis of the global drug delivery ...
Business Insider

GeoVax and PharmaJet to Collaborate On Development of Needle-Free Vaccine for Zika Virus

GeoVax Zika Virus Vaccine Provided 100% Protection in Animal Challenge Model ATLANTA, GA, Aug. 21, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human ...
Business Wire

PharmaJet Partner Zydus Cadila Announces Emergency Use Authorization Approval for World’s First Plasmid DNA COVID-19 Vaccine

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, the maker of innovative, needle-free injection technology, today announced that its partner, Zydus Cadila, has received the Emergency Use Authorization ...
MarketWatch

Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans

HONG KONG, June 19, 2025 /PRNewswire/ -- Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboration ...
Pharmabiz

Brazilian Tuberculosis Research Network to evaluate PharmaJet needle-free Tropis ID injection device as delivery system for tuberculin skin test

Brazilian Tuberculosis Research Network to evaluate PharmaJet needle-free Tropis ID injection device as delivery system for tuberculin skin test: Golden, Colorado Thursday, March ...